Position in RLMD
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$13
+$4 QoQ
Shares Held
2
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#126
of 126 holders
Holding Since
Mar 2023
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RLMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Front Row Advisors LLC holds $551,277 across 11 Biotechnology names. RLMD ranks #8 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABUS |
Arbutus Biopharma Corp
|
110,500 | $530,400 | |
| 2 | BNTX |
BioNTech SE
|
80 | $7,444 | |
| 3 | CRSP |
CRISPR Therapeutics AG
|
134 | $7,308 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
9 | $2,168 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
7 | $2,107 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2 | $1,247 | |
| 7 | VKTX |
Viking Therapeutics, Inc.
|
15 | $585 | |
| 8 | RLMD |
Relmada Therapeutics, Inc.
This page
|
2 | $13 |
All Filings in RLMD
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13 | 2 | Shares | Sole | 2026-08-13 | |
| 2025-12-31 | $9 | 2 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $4 | 2 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $1 | 3 | Shares | Sole | 2025-08-18 | |
| 2025-03-31 | $1 | 6 | Shares | Sole | 2025-05-15 | |
| 2024-09-30 | $19 | 6 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $18 | 6 | Shares | Sole | 2024-08-16 | |
| 2024-03-31 | $27 | 6 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $24 | 6 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $18 | 6 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $14 | 6 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $13 | 6 | Shares | Sole | 2023-05-23 | |
| No filing history on record for this holder in this stock. | ||||||